Cargando…

Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer

The effectiveness of neoadjuvant immune checkpoint inhibitor (ICI) therapy is confirmed in clinical trials; however, the patients suitable for receiving this therapy remain unspecified. Previous studies have demonstrated that the tumor microenvironment (TME) dominates immunotherapy; therefore, an ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jia‐Bin, Qiu, Qing‐Zhu, Zheng, Qiao‐Ling, Zhao, Ya‐Jun, Xu, Yu, Zhang, Tao, Wang, Shuan‐Hu, Wang, Quan, Jin, Qin‐Wen, Ye, Yin‐Hua, Li, Ping, Xie, Jian‐Wei, Lin, Jian‐Xian, Lu, Jun, Chen, Qi‐Yue, Cao, Long‐Long, Yang, Ying‐Hong, Zheng, Chao‐Hui, Huang, Chang‐Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214263/ https://www.ncbi.nlm.nih.gov/pubmed/36998102 http://dx.doi.org/10.1002/advs.202207417

Ejemplares similares

Immunotherapeutic implications of the immunophenotype of pediatric brain tumors
por: Griesinger, Andrea M, et al.
Publicado: (2014)

The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

Immunogenomic characterization in gastric cancer identifies microenvironmental and immunotherapeutically relevant gene signatures
por: Han, Xiao, et al.
Publicado: (2021)

Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
por: Zhang, Simeng, et al.
Publicado: (2021)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022)

Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer
por: Liu, YaLing, et al.
Publicado: (2023)

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2020)

Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma
por: Feng, Chenzhao, et al.
Publicado: (2022)

Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer
por: Sun, YuQin, et al.
Publicado: (2023)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

Immunophenotypes and Immune Markers Associated with Acute Promyelocytic Leukemia Prognosis
por: Xu, Fang, et al.
Publicado: (2014)

Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma
por: Long, Guo, et al.
Publicado: (2023)

Spatial immunophenotypes orchestrate prognosis in triple-negative breast cancer with Miller-Payne grade 4 following neoadjuvant chemotherapy
por: Ma, Jianli, et al.
Publicado: (2023)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer
por: Song, Li, et al.
Publicado: (2023)

Prognostic Value of Tumor Size in Patients with Remnant Gastric Cancer: Is the Seventh UICC Stage Sufficient for Predicting Prognosis?
por: Lu, Jun, et al.
Publicado: (2014)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer
por: Lin, Guang-Tan, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

Construction of a miRNA Signature Using Support Vector Machine to Identify Microsatellite Instability Status and Prognosis in Gastric Cancer
por: Wang, Ya-nan, et al.
Publicado: (2022)

CDK5RAP3 Inhibits the Translocation of MCM6 to Influence the Prognosis in Gastric Cancer
por: Chen, Qi-Yue, et al.
Publicado: (2019)

m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer
por: Lin, Jian-Xian, et al.
Publicado: (2022)

Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer
por: Qiu, Feng, et al.
Publicado: (2021)

A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma
por: Tian, Xiao-Mao, et al.
Publicado: (2022)

A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer
por: Liu, Shi-jin, et al.
Publicado: (2021)

Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Lin, Jian-Xian, et al.
Publicado: (2022)

A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms
por: Cao, Long-Long, et al.
Publicado: (2016)

Down-regulated expression of CDK5RAP3 and UFM1 suggests a poor prognosis in gastric cancer patients
por: Lin, Mi, et al.
Publicado: (2022)

Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis
por: Zhang, Shuwen, et al.
Publicado: (2022)

Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy
por: Guo, Liang, et al.
Publicado: (2020)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Molecular subtypes based on DNA sensors predict prognosis and tumor immunophenotype in hepatocellular carcinoma
por: Lin, Hong-Sheng, et al.
Publicado: (2023)

Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma
por: Sun, Bao-Ye, et al.
Publicado: (2023)

Effect of Plasma Viremia on Apoptosis and Immunophenotype of Dendritic Cells Subsets in Acute SIVmac239 Infection of Chinese Rhesus Macaques
por: Xia, Hou-Jun, et al.
Publicado: (2011)

Low Expression of CDK5 and p27 Are Associated with Poor Prognosis in Patients with Gastric Cancer
por: Sun, Yu-Qin, et al.
Publicado: (2016)

Characteristic immunophenotype and gene co-mutational status orchestrate to optimize the prognosis of CEBPA mutant acute myeloid leukemia
por: Chen, Xinjie, et al.
Publicado: (2023)

Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer
por: Qiu, Xiang-Ting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4d2odkc0kg6i0n84ubjtei8cb7